These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9326238)

  • 21. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria.
    Kinoshita T; Inoue N
    Int J Hematol; 2002 Feb; 75(2):117-22. PubMed ID: 11939256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-thymocyte globulin treatment of a patient for paroxysmal nocturnal haemoglobinuria-aplastic anaemia syndrome: complement activation and transient decrease of the PNH clone.
    Ebenbichler CF; Würzner R; Sandhofer AD; Niederwieser D; Dierich MP; Patsch JR
    Immunobiology; 1996-1997; 196(5):513-21. PubMed ID: 9145329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones.
    Park SH; Jeong J; Lee SH; Yoo DW; Choi Y; Jo JC; Lim JH
    Ann Lab Med; 2019 Mar; 39(2):150-157. PubMed ID: 30430777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effects of interferon-gamma and tumor necrosis factor-alpha on CD34+ bone marrow progenitor cells from aplastic anemia patients and normal donors.
    Welsh JP; Rutherford TR; Flynn J; Foukaneli T; Gordon-Smith EC; Gibson FM
    Hematol J; 2004; 5(1):39-46. PubMed ID: 14745429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes.
    Iwanaga M; Furukawa K; Amenomori T; Mori H; Nakamura H; Fuchigami K; Kamihira S; Nakakuma H; Tomonaga M
    Br J Haematol; 1998 Jul; 102(2):465-74. PubMed ID: 9695961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
    Feng X; Chuhjo T; Sugimori C; Kotani T; Lu X; Takami A; Takamatsu H; Yamazaki H; Nakao S
    Blood; 2004 Oct; 104(8):2425-31. PubMed ID: 15217832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure.
    Sugimori C; Mochizuki K; Qi Z; Sugimori N; Ishiyama K; Kondo Y; Yamazaki H; Takami A; Okumura H; Nakao S
    Br J Haematol; 2009 Oct; 147(1):102-12. PubMed ID: 19656154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysplasia and PNH-type cells in bone marrow aspirates of myelodysplastic syndromes.
    Westers TM; Alhan C; Visser-Wisselaar HA; Chitu DA; van de Loosdrecht AA
    Cytometry B Clin Cytom; 2023 Mar; 104(2):162-172. PubMed ID: 34806840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
    Maciejewski JP; Follmann D; Nakamura R; Saunthararajah Y; Rivera CE; Simonis T; Brown KE; Barrett JA; Young NS
    Blood; 2001 Dec; 98(13):3513-9. PubMed ID: 11739151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-RAS gene mutation in patients with aplastic anemia and aplastic anemia/ paroxysmal nocturnal hemoglobinuria during evolution to clonal disease.
    Mortazavi Y; Tooze JA; Gordon-Smith EC; Rutherford TR
    Blood; 2000 Jan; 95(2):646-50. PubMed ID: 10627475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clonal hematopoiesis in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
    Makishima H
    Rinsho Ketsueki; 2022; 63(9):1042-1045. PubMed ID: 36198527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.
    Wang SA; Pozdnyakova O; Jorgensen JL; Medeiros LJ; Stachurski D; Anderson M; Raza A; Woda BA
    Haematologica; 2009 Jan; 94(1):29-37. PubMed ID: 19001281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
    Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
    Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardized high-sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders: A single center US study.
    Donohue RE; Marcogliese AN; Sasa GS; Elghetany MT; Redkar AA; Bertuch AA; Curry CV
    Cytometry B Clin Cytom; 2018 Jul; 94(4):699-704. PubMed ID: 28574201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria.
    Heeney MM; Ormsbee SM; Moody MA; Howard TA; DeCastro CM; Ware RE
    Mol Genet Metab; 2003 Apr; 78(4):291-4. PubMed ID: 12706380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.
    Yang W; Zhao X; Peng G; Zhang L; Jing L; Zhou K; Li Y; Ye L; Li Y; Li J; Fan H; Yang Y; Zhang F
    Ann Hematol; 2021 Oct; 100(10):2435-2441. PubMed ID: 34269836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cells in paroxysmal nocturnal haemoglobinuria and aplastic anaemia: increasing evidence for overlap of haemopoietic defect.
    Marsh JC; Elebute MO
    Transfus Med; 2003 Dec; 13(6):377-86. PubMed ID: 14651743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells.
    Pu JJ; Hu R; Mukhina GL; Carraway HE; McDevitt MA; Brodsky RA
    Haematologica; 2012 Aug; 97(8):1225-33. PubMed ID: 22315493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria.
    Escalante CP; Chisolm S; Song J; Richardson M; Salkeld E; Aoki E; Garcia-Manero G
    Cancer Med; 2019 Feb; 8(2):543-553. PubMed ID: 30632713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.